Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome

Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to exam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proteomics. Clinical applications 2007-07, Vol.1 (7), p.699-711
Hauptverfasser: Berven, Frode S., Kroksveen, Ann C., Berle, Magnus, Rajalahti, Tarja, Flikka, Kristian, Arneberg, Reidar, Myhr, Kjell-Morten, Vedeler, Christian, Kvalheim, Olav M., Ulvik, Rune J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 711
container_issue 7
container_start_page 699
container_title Proteomics. Clinical applications
container_volume 1
creator Berven, Frode S.
Kroksveen, Ann C.
Berle, Magnus
Rajalahti, Tarja
Flikka, Kristian
Arneberg, Reidar
Myhr, Kjell-Morten
Vedeler, Christian
Kvalheim, Olav M.
Ulvik, Rune J.
description Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to examine the influence of pre‐analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut‐off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut‐off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at –80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein‐protein interactions. A spin cartridge with cut‐off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre‐analytical protocols for the proteomic study of CSF.
doi_str_mv 10.1002/prca.200700126
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_816528601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20326817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4136-860558ef754dfc548835590f379f36b032a7da11068c96f31eee197361a6c0d33</originalsourceid><addsrcrecordid>eNqFkM9P2zAYhi00BKXblePk03ZK8Y_YTo6sGhSBCkMMjpbrfBnenKTYiUr_e1wVKk7jZB-e533tF6FjSiaUEHayDNZMGCGKEMrkHhrRQrKs4CL_tLvn8hAdxfiXEJEzRQ7QIaOUS8XECP26CZCZ1vh176zx2LW1H6C1gLsW94-AfbfCTefBDt4EvAL357HHFgIsQheXLpk4Ga7Cy9D10DXwGe3Xxkf48nqO0e-zn3fTWXZ1fX4xPb3KbJ7Ks0ISIQqolcir2oq8SG8WJam5KmsuF4QzoypDKZGFLWXNKQDQUnFJjbSk4nyMvm9zU_HTALHXjYsWvDctdEPUBZWCpRaayG__JVkqkwVVCZxsQZv-FgPUehlcY8JaU6I3c-vN3Ho3dxK-viYPiwaqHf62bwLKLbByHtYfxOmb2-np-_Bs67rYw_PONeGflooroR_m5_qeifv55Wymf_AXVf-auQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20326817</pqid></control><display><type>article</type><title>Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome</title><source>Wiley Online Library</source><creator>Berven, Frode S. ; Kroksveen, Ann C. ; Berle, Magnus ; Rajalahti, Tarja ; Flikka, Kristian ; Arneberg, Reidar ; Myhr, Kjell-Morten ; Vedeler, Christian ; Kvalheim, Olav M. ; Ulvik, Rune J.</creator><creatorcontrib>Berven, Frode S. ; Kroksveen, Ann C. ; Berle, Magnus ; Rajalahti, Tarja ; Flikka, Kristian ; Arneberg, Reidar ; Myhr, Kjell-Morten ; Vedeler, Christian ; Kvalheim, Olav M. ; Ulvik, Rune J.</creatorcontrib><description>Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to examine the influence of pre‐analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut‐off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut‐off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at –80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein‐protein interactions. A spin cartridge with cut‐off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre‐analytical protocols for the proteomic study of CSF.</description><identifier>ISSN: 1862-8346</identifier><identifier>EISSN: 1862-8354</identifier><identifier>DOI: 10.1002/prca.200700126</identifier><identifier>PMID: 21136725</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Biomarker discovery ; Cerebrospinal fluid ; Mass spectra ; Pre-analytical ; Principal component analysis</subject><ispartof>Proteomics. Clinical applications, 2007-07, Vol.1 (7), p.699-711</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>Copyright © 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4136-860558ef754dfc548835590f379f36b032a7da11068c96f31eee197361a6c0d33</citedby><cites>FETCH-LOGICAL-c4136-860558ef754dfc548835590f379f36b032a7da11068c96f31eee197361a6c0d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fprca.200700126$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fprca.200700126$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21136725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berven, Frode S.</creatorcontrib><creatorcontrib>Kroksveen, Ann C.</creatorcontrib><creatorcontrib>Berle, Magnus</creatorcontrib><creatorcontrib>Rajalahti, Tarja</creatorcontrib><creatorcontrib>Flikka, Kristian</creatorcontrib><creatorcontrib>Arneberg, Reidar</creatorcontrib><creatorcontrib>Myhr, Kjell-Morten</creatorcontrib><creatorcontrib>Vedeler, Christian</creatorcontrib><creatorcontrib>Kvalheim, Olav M.</creatorcontrib><creatorcontrib>Ulvik, Rune J.</creatorcontrib><title>Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome</title><title>Proteomics. Clinical applications</title><addtitle>Prot. Clin. Appl</addtitle><description>Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to examine the influence of pre‐analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut‐off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut‐off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at –80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein‐protein interactions. A spin cartridge with cut‐off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre‐analytical protocols for the proteomic study of CSF.</description><subject>Biomarker discovery</subject><subject>Cerebrospinal fluid</subject><subject>Mass spectra</subject><subject>Pre-analytical</subject><subject>Principal component analysis</subject><issn>1862-8346</issn><issn>1862-8354</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkM9P2zAYhi00BKXblePk03ZK8Y_YTo6sGhSBCkMMjpbrfBnenKTYiUr_e1wVKk7jZB-e533tF6FjSiaUEHayDNZMGCGKEMrkHhrRQrKs4CL_tLvn8hAdxfiXEJEzRQ7QIaOUS8XECP26CZCZ1vh176zx2LW1H6C1gLsW94-AfbfCTefBDt4EvAL357HHFgIsQheXLpk4Ga7Cy9D10DXwGe3Xxkf48nqO0e-zn3fTWXZ1fX4xPb3KbJ7Ks0ISIQqolcir2oq8SG8WJam5KmsuF4QzoypDKZGFLWXNKQDQUnFJjbSk4nyMvm9zU_HTALHXjYsWvDctdEPUBZWCpRaayG__JVkqkwVVCZxsQZv-FgPUehlcY8JaU6I3c-vN3Ho3dxK-viYPiwaqHf62bwLKLbByHtYfxOmb2-np-_Bs67rYw_PONeGflooroR_m5_qeifv55Wymf_AXVf-auQ</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Berven, Frode S.</creator><creator>Kroksveen, Ann C.</creator><creator>Berle, Magnus</creator><creator>Rajalahti, Tarja</creator><creator>Flikka, Kristian</creator><creator>Arneberg, Reidar</creator><creator>Myhr, Kjell-Morten</creator><creator>Vedeler, Christian</creator><creator>Kvalheim, Olav M.</creator><creator>Ulvik, Rune J.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070701</creationdate><title>Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome</title><author>Berven, Frode S. ; Kroksveen, Ann C. ; Berle, Magnus ; Rajalahti, Tarja ; Flikka, Kristian ; Arneberg, Reidar ; Myhr, Kjell-Morten ; Vedeler, Christian ; Kvalheim, Olav M. ; Ulvik, Rune J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4136-860558ef754dfc548835590f379f36b032a7da11068c96f31eee197361a6c0d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biomarker discovery</topic><topic>Cerebrospinal fluid</topic><topic>Mass spectra</topic><topic>Pre-analytical</topic><topic>Principal component analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berven, Frode S.</creatorcontrib><creatorcontrib>Kroksveen, Ann C.</creatorcontrib><creatorcontrib>Berle, Magnus</creatorcontrib><creatorcontrib>Rajalahti, Tarja</creatorcontrib><creatorcontrib>Flikka, Kristian</creatorcontrib><creatorcontrib>Arneberg, Reidar</creatorcontrib><creatorcontrib>Myhr, Kjell-Morten</creatorcontrib><creatorcontrib>Vedeler, Christian</creatorcontrib><creatorcontrib>Kvalheim, Olav M.</creatorcontrib><creatorcontrib>Ulvik, Rune J.</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Proteomics. Clinical applications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berven, Frode S.</au><au>Kroksveen, Ann C.</au><au>Berle, Magnus</au><au>Rajalahti, Tarja</au><au>Flikka, Kristian</au><au>Arneberg, Reidar</au><au>Myhr, Kjell-Morten</au><au>Vedeler, Christian</au><au>Kvalheim, Olav M.</au><au>Ulvik, Rune J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome</atitle><jtitle>Proteomics. Clinical applications</jtitle><addtitle>Prot. Clin. Appl</addtitle><date>2007-07-01</date><risdate>2007</risdate><volume>1</volume><issue>7</issue><spage>699</spage><epage>711</epage><pages>699-711</pages><issn>1862-8346</issn><eissn>1862-8354</eissn><abstract>Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to examine the influence of pre‐analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut‐off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut‐off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at –80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein‐protein interactions. A spin cartridge with cut‐off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre‐analytical protocols for the proteomic study of CSF.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>21136725</pmid><doi>10.1002/prca.200700126</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1862-8346
ispartof Proteomics. Clinical applications, 2007-07, Vol.1 (7), p.699-711
issn 1862-8346
1862-8354
language eng
recordid cdi_proquest_miscellaneous_816528601
source Wiley Online Library
subjects Biomarker discovery
Cerebrospinal fluid
Mass spectra
Pre-analytical
Principal component analysis
title Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pre-analytical%20influence%20on%20the%20low%20molecular%20weight%20cerebrospinal%20fluid%20proteome&rft.jtitle=Proteomics.%20Clinical%20applications&rft.au=Berven,%20Frode%20S.&rft.date=2007-07-01&rft.volume=1&rft.issue=7&rft.spage=699&rft.epage=711&rft.pages=699-711&rft.issn=1862-8346&rft.eissn=1862-8354&rft_id=info:doi/10.1002/prca.200700126&rft_dat=%3Cproquest_cross%3E20326817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20326817&rft_id=info:pmid/21136725&rfr_iscdi=true